Filing Details
- Accession Number:
- 0001214659-21-003192
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-16 17:35:38
- Reporting Period:
- 2021-03-12
- Accepted Time:
- 2021-03-16 17:35:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1581280 | Twist Bioscience Corp | TWST | Biological Products, (No Disgnostic Substances) (2836) | 462058888 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1753655 | M. Emily Leproust | C/O Twist Bioscience Corporation 681 Gateway Blvd. South San Francisco CA 94080 | President & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-02-25 | 20,000 | $0.00 | 295,556 | No | 4 | G | Direct | |
| Common Stock | Disposition | 2021-02-25 | 20,000 | $0.00 | 275,556 | No | 4 | G | Direct | |
| Common Stock | Disposition | 2021-02-25 | 5,000 | $0.00 | 270,556 | No | 4 | G | Direct | |
| Common Stock | Disposition | 2021-03-12 | 500 | $136.79 | 270,056 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-12 | 200 | $137.81 | 269,856 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-12 | 200 | $139.25 | 269,656 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-12 | 200 | $140.22 | 269,456 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-12 | 900 | $141.76 | 268,556 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | G | Direct | |
| No | 4 | G | Direct | |
| No | 4 | G | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | $8.82 | 2027-09-28 | 0 | 230,794 | Direct | |
| Common Stock | Employee Stock Option (right to buy) | $26.66 | 2028-11-18 | 0 | 266,539 | Direct | |
| Common Stock | Employee Stock Option (right to buy) | $23.33 | 2029-10-23 | 0 | 131,290 | Direct | |
| Common Stock | Employee Stock Option (right to buy) | $5.95 | 2025-09-28 | 0 | 95,699 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2027-09-28 | 0 | 230,794 | Direct |
| 2028-11-18 | 0 | 266,539 | Direct |
| 2029-10-23 | 0 | 131,290 | Direct |
| 2025-09-28 | 0 | 95,699 | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $136.32 to $137.27 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $137.74 to $137.87 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $138.87 to $139.62 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $139.96 to $140.48 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $141.33 to $142.27 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Billionaire Hedge Funds
